Statin use in patients with hormone receptor-positive metastatic breast cancer treated with everolimus and exemestane.

Kyoungmin LeeEunjin NohSeok Joo MoonYoonjung Yoonie JooEun Joo KangJae Hong SeoIn Hae Park

Published in: Cancer medicine (2022)

Statins may have synergistic effects with endocrine therapy with the mTOR inhibitor everolimus, and improve survival in patients with HR+ metastatic breast cancer.

Keyphrases

metastatic breast cancer
cardiovascular disease
cell proliferation
coronary artery disease
cancer therapy
free survival
newly diagnosed
drug delivery